论文部分内容阅读
目的 探讨B超引导经皮穿刺注射平阳霉素治疗肝血管瘤(HA)的作用。方法 对20例接受本疗法患者的临床资料进行对比分析。结果 本组无严重并发症及死亡病例。治疗后05个月复查,所有患者的血管瘤均有明显缩小(血管瘤直径术前为5~18cm,术后为05~<5cm),且呈强回声结节,治愈率100%。随访2年,均无复发。结论 本疗法是一种安全、有效的治疗肝血管瘤的方法。
Objective To investigate the role of B-guided percutaneous injection of Pingyangmycin in the treatment of hepatic hemangioma (HA). Methods The clinical data of 20 patients receiving this therapy were compared and analyzed. Results There were no serious complications and deaths in this group. After 5 months of treatment, hemangiomas in all patients were significantly reduced (the diameter of the hemangiomas was 5 to 18 cm before surgery and 05 to <5 cm after the operation), and they were strong echo nodules. The cure rate was 100%. After 2 years of follow-up, there was no recurrence. Conclusion This therapy is a safe and effective method for the treatment of hepatic hemangiomas.